These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34104490)

  • 41. Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.
    Zugor V; Witt JH; Heidenreich A; Porres D; Labanaris AP
    Anticancer Res; 2012 May; 32(5):2091-5. PubMed ID: 22593494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
    Ribeiro L; Stonier T; Stroman L; Tourinho-Barbosa R; Alghazo O; Winkler M; Dasgupta P; Popert R; Cathelineau X; Sanchez-Salas R; Murphy DG; Emberton M; Cathcart P
    J Urol; 2021 Mar; 205(3):791-799. PubMed ID: 33021441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
    Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparing the Approach to Radical Prostatectomy Using the Multiport da Vinci Xi and da Vinci SP Robots: A Propensity Score Analysis of Perioperative Outcomes.
    Moschovas MC; Bhat S; Sandri M; Rogers T; Onol F; Mazzone E; Roof S; Mottrie A; Patel V
    Eur Urol; 2021 Mar; 79(3):393-404. PubMed ID: 33357994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy.
    Kim DK; Koo KC; Lee KS; Hah YS; Rha KH; Hong SJ; Chung BH
    J Korean Med Sci; 2018 Nov; 33(45):e285. PubMed ID: 30402050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.
    Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH
    J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical and oncological outcomes in patients with a preoperative PSA value <4 ng/ml undergoing robot-assisted radical prostatectomy.
    Zugor V; Labanaris AP; Bauer RM; Witt JH
    Anticancer Res; 2012 May; 32(5):2079-83. PubMed ID: 22593492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Learning curve of minimally invasive radical prostatectomy: Comprehensive evaluation and cumulative summation analysis of oncological outcomes.
    Sivaraman A; Sanchez-Salas R; Prapotnich D; Yu K; Olivier F; Secin FP; Barret E; Galiano M; Rozet F; Cathelineau X
    Urol Oncol; 2017 Apr; 35(4):149.e1-149.e6. PubMed ID: 28117215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does Presence of a Median Lobe Affect Perioperative Complications, Oncological Outcomes and Urinary Continence Following Robotic-assisted Radical Prostatectomy?
    Hamidi N; Atmaca AF; Canda AE; Keske M; Gok B; Koc E; Asil E; Ardicoglu A
    Urol J; 2018 Sep; 15(5):248-255. PubMed ID: 30178450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea.
    Yun JE; Lee NR; Kwak C; Rha KH; Seo SI; Hong SH; Lee YG; Park DA; Kim CS; Lee SH
    Prostate Int; 2019 Mar; 7(1):19-24. PubMed ID: 30937294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.
    Yuh B; Artibani W; Heidenreich A; Kimm S; Menon M; Novara G; Tewari A; Touijer K; Wilson T; Zorn KC; Eggener SE
    Eur Urol; 2014 May; 65(5):918-27. PubMed ID: 23721959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extraperitoneal Laparoscopic Versus Transperitoneal Robot-Assisted Laparoscopic Approaches for Extended Pelvic Lymph Node Dissection During Radical Prostatectomy.
    Yıldız A; Anıl H; Akdemir S; Aksaray EE; Ateş M; Arslan M
    J Laparoendosc Adv Surg Tech A; 2022 Apr; 32(4):355-359. PubMed ID: 33960836
    [No Abstract]   [Full Text] [Related]  

  • 55. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of unifocal and multifocal positive surgical margins in a large series of robot-assisted radical prostatectomy for prostate cancer.
    Keller EX; Bachofner J; Britschgi AJ; Saba K; Mortezavi A; Kaufmann B; Fankhauser CD; Wild P; Sulser T; Hermanns T; Eberli D; Poyet C
    World J Urol; 2019 Sep; 37(9):1837-1844. PubMed ID: 30519744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer.
    Montorsi F; Gandaglia G; Fossati N; Suardi N; Pultrone C; De Groote R; Dovey Z; Umari P; Gallina A; Briganti A; Mottrie A
    Eur Urol; 2017 Sep; 72(3):432-438. PubMed ID: 27600589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Pragmatic Randomized Controlled Trial Examining the Impact of the Retzius-sparing Approach on Early Urinary Continence Recovery After Robot-assisted Radical Prostatectomy.
    Dalela D; Jeong W; Prasad MA; Sood A; Abdollah F; Diaz M; Karabon P; Sammon J; Jamil M; Baize B; Simone A; Menon M
    Eur Urol; 2017 Nov; 72(5):677-685. PubMed ID: 28483330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience.
    Park J; Yoo DS; Song C; Park S; Park S; Kim SC; Cho Y; Ahn H
    World J Urol; 2014 Feb; 32(1):193-9. PubMed ID: 24062092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy.
    Fujimura T; Fukuhara H; Taguchi S; Yamada Y; Sugihara T; Nakagawa T; Niimi A; Kume H; Igawa Y; Homma Y
    BMC Cancer; 2017 Jun; 17(1):454. PubMed ID: 28662644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.